Entacapone

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.6, Iss.8, 2010-08, pp. : 983-993

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Entacapone in the management of Parkinson’s disease

By Waters Cheryl Henchcliffe Claire

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 7, 2002-07 ,pp. : 957-963

Informa Healthcare

Access to resources Recommend Favorite

Entacapone adjunctive therapy clear choice in Parkinson's disease

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 297, 2001-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Entacapone/Levodopa/Carbidopa Combination Tablet: Stalevo

By Limited A.I.

Drugs in R&D, Vol. 4, Iss. 5, 2003-01 ,pp. : 310-311

Adis International

Access to resources Recommend Favorite

Entacapone: A Review of its Use in Parkinson's Disease

By Holm K.J. Spencer C.M.

Drugs, Vol. 58, Iss. 1, 1999-07 ,pp. : 159-177

Adis International

Access to resources Recommend Favorite

Effects of entacapone and tolcapone on mitochondrial membrane potential

By Haasio K. Koponen A. Penttila K.E. Nissinen E.

European Journal of Pharmacology, Vol. 453, Iss. 1, 2002-10 ,pp. : 21-26

Elsevier

Access to resources Recommend Favorite